[1]
S. K. BHARDWAJ, “Pharmaco-Epigenomic Reprogramming as the Next Therapeutic Frontier”, J. Public Health Prev. Med., vol. 2, no. 4, pp. 18–20, Apr. 2026, doi: 10.64904/fpm2026.023.